complementary 7-valent pneumococcal conjugate vaccine (PF-06842433) / Pfizer - LARVOL DELTA

Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants (clinicaltrials.gov) - P2; N=560; Terminated; Sponsor: Pfizer; Completed ➔ Terminated; Study vaccinations and blood draws were halted due to adequacy of a smaller dataset and study feasibility issues. It was not based on any safety concerns.

Clinical • Trial termination • Infectious Disease

Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants (clinicaltrialsregister.eu) - P2; N=565; Sponsor: Pfizer, Inc.

Clinical • New P2 trial • Infectious Disease